GO:0015217 ADP transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015217 (ADP transmembrane transporter activity) is a molecular function that enables the transfer of ADP (adenosine diphosphate) across a membrane.
• ADP transport is essential for mitochondrial energy metabolism, where the adenine nucleotide translocase exchanges ADP and ATP across the inner mitochondrial membrane.
• Defects in ADP transport are linked to mitochondrial dysfunction, which can inhibit lysosomal hydrolysis and contribute to neurodegeneration.
• ADP also acts as a signaling molecule in the extracellular space, where it is metabolized by ectoenzymes such as CD38, connecting cardiac and neural function.
• Studying ADP transmembrane transporter activity requires methods that measure transport kinetics, membrane potential, and cellular metabolism.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are powerful tools to dissect the causal role of ADP transporter genes in health and disease.
Description
ADP transmembrane transporter activity (GO:0015217) is a molecular function that enables the movement of adenosine diphosphate (ADP) across biological membranes. This activity is fundamental to cellular energy metabolism, as ADP is a key substrate for ATP synthesis and a product of ATP hydrolysis. In mitochondria, the exchange of ADP and ATP across the inner membrane is mediated by the adenine nucleotide translocase (ANT), a critical component of oxidative phosphorylation. Beyond mitochondria, ADP transport also occurs in other cellular compartments and in the extracellular space, where ADP serves as a signaling molecule. Understanding the mechanisms and regulation of ADP transport is therefore essential for researchers studying bioenergetics, cell signaling, and disease pathogenesis.
ADP transmembrane transporter activity At A Glance
| GO ID | GO:0015217 |
|---|---|
| GO term | ADP transmembrane transporter activity |
| Ontology | molecular_function |
| Synonym | None |
| Major function | Transfer of ADP across a membrane |
| Substrates | ADP (adenosine diphosphate) |
| Cellular locations | Mitochondrial inner membrane, plasma membrane, other organelle membranes |
| Related processes | Oxidative phosphorylation, nucleotide metabolism, purinergic signaling |
| Representative proteins | Adenine nucleotide translocase (ANT/SLC25A4-6), CD38, other mitochondrial carriers |
What Is GO:0015217?
According to the Gene Ontology, GO:0015217 (ADP transmembrane transporter activity) is defined as enabling the transfer of ADP, adenosine diphosphate, from one side of a membrane to the other. This activity is carried out by integral membrane proteins that facilitate the movement of ADP across lipid bilayers, often in exchange for other nucleotides such as ATP or in response to electrochemical gradients.
Why Is ADP transmembrane transporter activity Important in Cell Biology?
ADP transmembrane transporter activity is central to cellular energy homeostasis and signaling. In mitochondria, the import of ADP and export of ATP by the adenine nucleotide translocase is required for oxidative phosphorylation, and its dysfunction leads to severe metabolic and neurodegenerative disorders. In the extracellular space, ADP released from cells acts as a danger signal and platelet activator, and its transport and metabolism are implicated in cardiovascular and neurological diseases. Thus, understanding ADP transport mechanisms provides insights into fundamental biology and potential therapeutic targets.
• Essential for mitochondrial ATP production by supplying ADP to the ATP synthase.
• Regulates cellular energy charge and metabolic flux.
• Involved in purinergic signaling, influencing platelet aggregation and vascular tone.
• Dysfunction is linked to mitochondrial myopathies and neurodegenerative diseases.
• Plays a role in lysosomal function and autophagy, as mitochondrial respiratory chain deficiency inhibits lysosomal hydrolysis.
• Contributes to intestinal epithelial barrier function through autophagy regulation.
• Target for drug development in cardiovascular and metabolic disorders.
• Key to understanding CD38-mediated NAD+ metabolism and its impact on heart and brain.
• Required for proper neuronal function, as ADP transport defects can impair neuronal survival.
• Provides a model for studying membrane transport kinetics and bioenergetics.
What Happens During ADP transmembrane transporter activity?
Substrate Recognition and Binding
In simple terms: The transporter first grabs ADP from one side of the membrane.
ADP transmembrane transporters, such as the mitochondrial adenine nucleotide translocase (ANT), possess a binding site that specifically recognizes ADP. The binding is driven by electrostatic interactions between the negatively charged phosphate groups of ADP and positively charged residues in the transporter's cavity. This step ensures selectivity for ADP over other nucleotides like ATP or AMP.
Conformational Change and Translocation
In simple terms: The transporter changes shape to move ADP across the membrane.
Upon ADP binding, the transporter undergoes a conformational change that opens a channel to the opposite side of the membrane. In the case of ANT, this involves a switch between cytoplasmic and matrix-facing states, coupled to the exchange of ADP for ATP. The process is driven by the electrochemical gradient and the concentration difference of adenine nucleotides across the membrane.
Release of ADP and Reset
In simple terms: ADP is released on the other side, and the transporter resets.
After translocation, ADP is released into the target compartment (e.g., the mitochondrial matrix), where it can be used by ATP synthase. The transporter then returns to its original conformation to bind a new molecule of ADP or ATP, completing the transport cycle. This cycle is highly efficient and can be regulated by factors such as membrane potential and nucleotide concentrations.
Regulation by Membrane Potential and pH
In simple terms: The electrical charge and acidity of the environment affect how well the transporter works.
ADP transport is sensitive to the mitochondrial transmembrane potential, which is maintained by the electron transport chain. Changes in membrane potential can alter the rate of ADP uptake, thereby matching ATP production to cellular energy demand. Additionally, intracellular pH can influence the protonation state of ADP and the transporter, affecting activity.
Key Genes Involved in GO:0015217 ADP transmembrane transporter activity
The following genes encode proteins that exhibit ADP transmembrane transporter activity or are directly involved in ADP transport and its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC25A4 (ANT1) | Mitochondrial ADP/ATP translocase 1 | Heart and muscle energy metabolism; mutations cause mitochondrial myopathy |
| SLC25A5 (ANT2) | Mitochondrial ADP/ATP translocase 2 | Highly expressed in proliferating cells; role in cancer metabolism |
| SLC25A6 (ANT3) | Mitochondrial ADP/ATP translocase 3 | Housekeeping isoform; implicated in apoptosis |
| SLC25A31 (ANT4) | Mitochondrial ADP/ATP translocase 4 | Testis-specific; required for spermatogenesis |
| CD38 | Ectoenzyme that hydrolyzes NAD+ and ADP-ribose; produces ADP-ribose | Immune function, cardiac and brain signaling |
| VDAC1 | Voltage-dependent anion channel; transports ADP/ATP across outer mitochondrial membrane | Mitochondrial permeability transition; apoptosis |
| VDAC2 | Voltage-dependent anion channel 2 | Mitochondrial metabolism; apoptosis regulation |
| VDAC3 | Voltage-dependent anion channel 3 | Mitochondrial function; sperm motility |
| ATP5F1A | ATP synthase subunit alpha; uses ADP to produce ATP | Oxidative phosphorylation; mitochondrial disease |
| ATP5F1B | ATP synthase subunit beta; catalytic subunit | ATP synthesis; mutations cause neuropathy |
| ATP5MC1 | ATP synthase membrane subunit c locus 1 | Proton translocation; mitochondrial disorders |
| ATP5MC2 | ATP synthase membrane subunit c locus 2 | Mitochondrial ATP production |
| ATP5MC3 | ATP synthase membrane subunit c locus 3 | Mitochondrial bioenergetics |
| ATP5PB | ATP synthase peripheral stalk subunit b | ATP synthase assembly |
| ATP5PD | ATP synthase peripheral stalk subunit d | Mitochondrial ATP synthesis |
| ATP5PF | ATP synthase peripheral stalk subunit F6 | Regulation of ATP synthase |
| ATP5PO | ATP synthase subunit O | Mitochondrial ATP synthase complex |
How Is ADP transmembrane transporter activity Regulated?
ADP transmembrane transporter activity is regulated at multiple levels. The mitochondrial adenine nucleotide translocase (ANT) is inhibited by high concentrations of ADP (ADP-inhibition) and by the mitochondrial membrane potential. Additionally, post-translational modifications such as phosphorylation and acetylation can modulate ANT activity. In the extracellular space, CD38-mediated ADP-ribose metabolism influences ADP levels and purinergic signaling. Autophagy and lysosomal function also impact mitochondrial turnover and thus ADP transport capacity.
ADP transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC25A4 | Mitochondrial myopathy, cardiomyopathy | Knockout mouse, patient-derived iPSCs |
| CD38 | Heart failure, neurodegeneration | CD38 knockout mice, neuronal cultures |
| VDAC1 | Apoptosis dysregulation, cancer | VDAC1 knockout cell lines |
| ATP5F1A | Mitochondrial encephalopathy | Point-mutation knock-in mice |
| SLC25A5 | Cancer proliferation | Overexpression in cancer cell lines |
Mitochondrial Myopathies and Neurodegeneration
Mutations in SLC25A4 (ANT1) cause mitochondrial myopathy with lactic acidosis and hypertrophic cardiomyopathy, highlighting the critical role of ADP transport in muscle and heart function. Mitochondrial respiratory chain deficiency, which impairs ADP transport indirectly, inhibits lysosomal hydrolysis and contributes to neurodegeneration. Furthermore, autophagy defects in intestinal epithelial cells can lead to barrier dysfunction and inflammation.
Cardiovascular and Neurological Disorders
CD38, an ectoenzyme that regulates ADP-ribose and NAD+ levels, connects cardiac and brain function. Dysregulation of CD38 is implicated in heart failure and neurodegenerative diseases, partly through altered purinergic signaling involving ADP. ADP also acts as a platelet agonist, and its transport and metabolism influence thrombosis risk.
Cancer Metabolism
Cancer cells often reprogram energy metabolism, and ANT isoforms such as SLC25A5 (ANT2) are overexpressed in proliferating cells to support high ATP demand. Targeting ADP transport may therefore offer therapeutic opportunities in cancer.
From ADP transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLC25A4 impair ADP transport? | SLC25A4 knockout cell line (e.g., HEK293T) |
| How does a specific ANT1 mutation affect transport? | Point-mutation knock-in of SLC25A4 in iPSCs |
| Can we visualize ADP transport in live cells? | Tagged knock-in of SLC25A4 with fluorescent protein |
| Does CD38 overexpression alter ADP levels? | CD38 overexpression in neuronal cell lines |
| What is the role of VDAC1 in ADP flux? | VDAC1 knockout in HeLa cells |
| Can we screen for modulators of ADP transport? | CRISPR library screening in mitochondrial reporter cells |
How to Study the ADP transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| TMRE staining | Mitochondrial membrane potential | Assessment of mitochondrial function |
| Genetically encoded pH biosensor | Lysosomal pH | Live imaging of autophagy |
| RNA-seq | Gene expression changes | Profiling of ADP transporter genes in disease models |
| Autophagy flux assay | Autophagosome turnover | Studying lysosomal hydrolysis |
| ADP uptake assay | Rate of ADP transport | Kinetic analysis of transporters |
| ATP synthesis assay | ATP production | Mitochondrial bioenergetics |
| CD38 enzymatic activity assay | NAD+ hydrolysis and ADP-ribose production | Purinergic signaling studies |
Measuring Mitochondrial Transmembrane Potential
TMRE staining is a widely used method to assess mitochondrial membrane potential, which drives ADP transport. This protocol allows live-cell imaging and quantification of mitochondrial function.
Live Imaging of Intra-lysosome pH
Genetically encoded biosensors can monitor lysosomal pH, which is linked to mitochondrial function and ADP transport. This method is useful for studying autophagy and lysosomal hydrolysis defects.
RNA Profiling of Infected Cells
Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals changes in gene expression related to mitochondrial function and ADP transport, providing insights into viral pathogenesis.
Autophagy Flux Analysis
Autophagy controls the intestinal epithelial barrier, and measuring autophagic flux can reveal how ADP transport defects affect lysosomal degradation and cellular homeostasis.
How CRISPR Can Be Used to Study GO:0015217 ADP transmembrane transporter activity
Knockout
CRISPR knockout of ADP transporter genes such as SLC25A4 or CD38 allows researchers to study loss-of-function phenotypes, including impaired mitochondrial respiration and altered signaling. For example, SLC25A4 knockout cells show reduced ADP uptake and ATP production.
Point Mutation
Introducing disease-associated point mutations (e.g., in SLC25A4) via CRISPR base editing or HDR enables the study of specific amino acid changes on transporter activity and their contribution to mitochondrial myopathy.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into endogenous ADP transporter genes allows real-time visualization of protein localization and dynamics in live cells, facilitating studies of transport mechanisms.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of ADP transporters like CD38 can model gain-of-function states observed in cancer or cardiovascular disease, helping to identify downstream effects on metabolism and signaling.
How EDITGENE Supports ADP transmembrane transporter activity Research
Researchers studying ADP transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in mitochondrial function, signaling, or disease. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional studies.
Contact EDITGENE today to design your custom CRISPR model for ADP transmembrane transporter activity research.
Frequently Asked Questions About ADP transmembrane transporter activity
What is ADP transmembrane transporter activity?
ADP transmembrane transporter activity (GO:0015217) is a molecular function that enables the transfer of ADP across a membrane, as defined by the Gene Ontology.
What genes are involved in ADP transmembrane transporter activity?
Key genes include SLC25A4, SLC25A5, SLC25A6, SLC25A31 (adenine nucleotide translocases), VDAC1-3, and CD38.
How is ADP transported across the mitochondrial membrane?
ADP is transported by the adenine nucleotide translocase (ANT) in exchange for ATP, driven by the mitochondrial membrane potential.
What diseases are associated with defects in ADP transport?
Defects in ADP transport are linked to mitochondrial myopathies, cardiomyopathies, neurodegeneration, and cancer.
What methods are used to study ADP transmembrane transporter activity?
Methods include TMRE staining for membrane potential, ADP uptake assays, ATP synthesis assays, and live-cell imaging with biosensors.
Can CRISPR be used to study ADP transporters?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect the function of ADP transporter genes.
What is the role of CD38 in ADP transport?
CD38 is an ectoenzyme that hydrolyzes NAD+ to ADP-ribose and regulates extracellular ADP levels, impacting cardiac and brain function.
How does mitochondrial membrane potential affect ADP transport?
The mitochondrial membrane potential provides the driving force for ADP uptake via ANT, and changes in potential alter transport rates.
What is the link between ADP transport and autophagy?
Mitochondrial respiratory chain deficiency, which affects ADP transport, inhibits lysosomal hydrolysis and impairs autophagy.
How can I model ADP transporter mutations in the lab?
EDITGENE offers CRISPR-based services to create knockout, point mutation, knock-in, and overexpression models for ADP transporter genes.
Conclusion
ADP transmembrane transporter activity (GO:0015217) is a fundamental molecular function that underpins cellular energy metabolism and signaling. Its dysregulation is implicated in a range of diseases, from mitochondrial myopathies to cardiovascular and neurological disorders. By leveraging CRISPR-based models and advanced research methods, scientists can unravel the precise roles of ADP transporters and develop targeted therapies. EDITGENE stands ready to support these efforts with tailored gene editing services.
References
- 1. Foerster EG et al.. 2022. How autophagy controls the intestinal epithelial barrier.. Autophagy 18(1):86-103 PMID: 33906557
- 2. Crowley LC et al.. 2016. Measuring Mitochondrial Transmembrane Potential by TMRE Staining.. Cold Spring Harb Protoc 2016(12) PMID: 27934682
- 3. Fernandez-Mosquera L et al.. 2019. Mitochondrial respiratory chain deficiency inhibits lysosomal hydrolysis.. Autophagy 15(9):1572-1591 PMID: 30917721
- 4. Selinger M et al.. 2022. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors.. Comput Struct Biotechnol J 20:2759-2777 PMID: 35685361
- 5. Ponsford AH et al.. 2021. Live imaging of intra-lysosome pH in cell lines and primary neuronal culture using a novel genetically encoded biosensor.. Autophagy 17(6):1500-1518 PMID: 32515674
- 7. Lapashina AS et al.. 2018. ADP-Inhibition of H+-F(O)F(1)-ATP Synthase.. Biochemistry (Mosc) 83(10):1141-1160 PMID: 30472953
- 8. Tao Y et al.. 2025. CD38 connects the heart and brain.. Transl Psychiatry 15(1):342 PMID: 40935818
